|
Market Closed -
OTC Markets
15:58:44 2026-10-21 EDT
|
5-day change | 1st Jan Change | ||
| 34.28 USD | -0.61% |
|
+6.23% | +19.03% |
| 08:39pm | Australia's CSL faces shareholder class action over forecast disclosures | RE |
| 07:26pm | CSL Faces Shareholder Class Action Over Alleged Disclosure Breaches, Fiscal 2026 Guidance | MT |
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
The annotated values (TR) are displayed with their "Total Return" performance (only if available).
End-of-day quotes
Compared values
| Sector | Change | 5-day change | YTD change | 1-year change | 5-year change | Capi. | ST | MT | LT | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CSL LIMITED | Biopharmaceuticals | -0.61% | +6.23% | +19.03% | -3.75% | -37.92% | 65.82B |
-
|
-
|
-
|
- Stock Market
- Stocks
- CSL Stock
- CSLLY Stock
- Charts CSL Limited
- Comparison Chart
Select your edition
All financial news and data tailored to specific country editions
